中国临床药理学与治疗学2024,Vol.29Issue(11) :1306-1314.DOI:10.12092/j.issn.1009-2501.2024.11.014

盐诱导激酶生理病理功能及其抑制剂的研究进展

Research progress on physiological and pathological functions of salt-inducible kinase and its inhibitors

林新悦 王艳艳 卞宏生 于爽 黄莉莉
中国临床药理学与治疗学2024,Vol.29Issue(11) :1306-1314.DOI:10.12092/j.issn.1009-2501.2024.11.014

盐诱导激酶生理病理功能及其抑制剂的研究进展

Research progress on physiological and pathological functions of salt-inducible kinase and its inhibitors

林新悦 1王艳艳 1卞宏生 1于爽 1黄莉莉1
扫码查看

作者信息

  • 1. 黑龙江中医药大学药学院,哈尔滨 150040,黑龙江
  • 折叠

摘要

盐诱导激酶(salt-inducible kinase,SIK)家族包括三种亚型,即SIK1、SIK2和SIK3,参与调控昼夜节律、睡眠-觉醒、抑郁症、糖脂代谢、肿瘤和炎症等多个生理病理过程.SIK抑制剂已经成为治疗多种疾病的候选开发药物,尤其有望成为一种治疗神经系统疾病(如睡眠障碍、昼夜节律紊乱、抑郁症等)的潜在新型药物.本文主要总结了 SIK的三种亚型及其上下游信号通路在多种生理病理过程中的调控作用及作用机制,并对SIK抑制剂的研究进展进行了总结与展望.

Abstract

The salt-inducible kinase(SIK)family includes three isoforms,SIK1,SIK2 and SIK3,which are the main regulators of physiological and patho-logical processes and participate in the regulation of glucose and lipid metabolism,tumor,inflamma-tion,depression,sleep-wake and circadian rhythm.SIK inhibitor has become a candidate drug for the treatment of a variety of diseases,and is especially expected to become a potential new drug for the treatment of nervous system diseases,such as sleep disorders,circadian rhythm disorders,and de-pression.This review summarizes the regulation and mechanism of three isoforms of SIK and their upstream and downstream signaling pathways in the above physiological and pathological processes.It also reviews the recentstudies of SIK inhibitors.

关键词

盐诱导激酶/中枢神经系统/糖脂代谢/炎症/骨关节/肿瘤/黑色素

Key words

salt-inducible kinase/central nervous system/metabolism/inflammation/osteoarthritis/cancer/melanin

引用本文复制引用

出版年

2024
中国临床药理学与治疗学
中国药理学会

中国临床药理学与治疗学

CSTPCD北大核心
影响因子:0.97
ISSN:1009-2501
段落导航相关论文